Pfizer and Moderna Better Get This Clarified’: Study Finds Worse Antibodies After mRNA Boosters
Adverse effects of COVID-19 vaccines
The coronavirus disease (COVID-19) pandemic has led to the widespread use of genetic vaccines, including mRNA and viral vector vaccines. In addition, booster vaccines have been used, but their effectiveness against the highly mutated spike protein of Omicron strains is limited. Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines and the waning of immunity with time. The study showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 vaccine was lower than that among unvaccinated individuals.
Some studies suggest a link between COVID-19 vaccines and reactivation of the virus that causes shingles. This condition is sometimes referred to as vaccine-acquired immunodeficiency syndrome [14]. Since December 2021, besides COVID-19, Department of Cardiovascular Surgery, Okamura Memorial Hospital, Shizuoka, Japan (hereinafter referred to as “the institute”) has encountered cases of infections that are difficult to control. For example, there were several cases of suspected infections due to inflammation after open-heart surgery, which could not be controlled even after several weeks of use of multiple antibiotics. The patients showed signs of being immunocompromised, and there were a few deaths. The risk of infection may increase.
Source: www.ncbi.nlm.nih.gov
Pfizer and Moderna better get this clarified’: Study finds worse antibodies after mRNA boosters
Increased proportion of post-booster IgG4 antibodies, known for helping humans adapt to allergies, “might result in longer viral persistence in case of infection,” German researchers conclude. Italian study found IgG4 concentration correlated with COVID-related mortality.
A new peer-reviewed study is raising concerns that a third dose of Pfizer and Moderna vaccines may actually worsen immune response against COVID-19, creating waves in both mainstream and heterodox COVID circles.
Published in Science Immunology last week, the study by German researchers found that mRNA boosting induced a high level of so-called IgG4 antibodies, a subclass known for prompting a mild immune response, in two cohorts of several dozen healthcare workers.
“Pfizer and Moderna better get this clarified,” California gastroenterologist Farid Jalali, who once pressured the FDA to fast-track COVID vaccines for infants, wrote in response to Topol before marking his account private.
The research is just the latest to prompt scrutiny of federal vaccine recommendations and ongoing professional and educational mandates, particularly for college students, a demographic with low COVID risks but elevated risks of post-jab heart inflammation.
The CDC, Pfizer and Moderna didn’t respond to queries.
Philippines doctor Michael David Sy, who wrote a book critical of the country’s COVID response, said the German research had prompted him to “recommend against mRNA boosters unless more studies debunk this one or more comprehensive studies surface.”
The IgG4 switch is “great if it’s a benign or inert substance, like pollen, but NOT with virulent entities like COVID-19,” Sy wrote. “Successive mRNA boosts no longer seem to be a salient answer in our fight against COVID-19.”
Former New York Times drug industry reporter Alex Berenson also invoked allergies as a common prompt for IgG4 response.
Unlike IgG1-3, the fourth subclass “does little to help other immune system cells attack viral or bacterial invaders directly,” Berenson wrote in a review of prior IgG4 research. Beekeepers, for example, have high IgG4 concentrations from repeat exposure to bee venom.
While the fourth subclass can still neutralize the virus and IgG antibodies aren’t the only defense, he said, the German research “offers more evidence that mRNA booster campaigns need to be immediately restricted.” Scientists also must study the post-vaccination sickness level of those with high IgG4 levels compared to those with low levels, Berenson said.
Source: justthenews.com
